Four dividend-paying healthcare stocks to consider in Biden’s era

Summary

  • AstraZeneca PLC (Nasdaq: AZN) pays an annual dividend of US$1.86 to shareholders.
  • Amgen Inc. (Nasdaq: AMGN) reported total revenue of US$5.9 billion in Q1, 2021.
  • Walgreens Boots Alliance, Inc. (Nasdaq: WBA) increased its annual dividend from US$1.87 to US$1.91 per share.

Healthcare stocks cover a broad range of companies. That include companies involved in the research and development of drugs, manufacturing medical devices, etc. Besides, they provide medical insurance cover, run hospital chains, and so on. However, not all healthcare stocks provide dividends. Here we explore four healthcare stocks that pay a dividend.

AstraZeneca PLC (Nasdaq: AZN)

AstraZeneca PLC, a biopharmaceutical company, develops medicines for various diseases like oncology, respiratory, infection, gastrointestinal, and cardiovascular. The company paid an annual dividend of US$1.86 to its shareholders.  

Its stock traded at US$57.08 at 11.09 am ET on July 26, down 1.94 percent from the previous close. Its market cap is US$150 billion. The stock gained 15.46 percent YTD.

Source: Pixabay.

The P/E ratio and the forward P/E ratio are 37.78 and 22.50, respectively. Earnings per share are US$1.52. The current yield is 3.28 percent, and the beta is 1. The 52 week highest stock price of AZN is US$64.94, and the lowest is US$46.48. The share volume is 41,041,221.

AZN reported total revenue of US$7.3 billion in Q1, 2021, compared to US$6.3 billion in Q1, 2020. The gross profit was US$5.3 billion against US$4.9 billion in Q1, 2020.

Also read: Top health stocks under US$50

Amgen Inc (Nasdaq: AMGN)

Amgen Inc is a biotechnology company, and develops therapies for various diseases. In addition, the company paid an annual dividend of US$7.04 to its shareholders.

Its stock traded at US$246.155 at 11.12 am ET on July 26, down 0.94 percent from the previous close. AMGN’s market cap is US$141 billion. The stock gained 7.35 percent YTD.

The P/E ratio and the forward P/E ratio are 20.43 and 15.04, respectively. Earnings per share are US$12.07. The current yield is 2.84 percent, and the beta is 1. The 52 week highest stock price of AMGN is US$276.69, and the lowest is US$210.28. The share volume is 1,041,782.

AMGN reported total revenue of US$5.9 billion in Q1, 2021, and US$6.1 billion in Q1, 2020. Its gross profit for the quarter was US$4.4 billion, and that of Q1, 2020, was US$4.6 billion. Operating income was US$2.1 billion in Q1, 2021, and that of Q1, 2020, was US$2 billion.

Source: Pixabay.

Gilead Sciences, Inc. (Nasdaq: GILD)

Gilead Sciences, Inc develops anti-viral drugs. he company paid an annual dividend of US$2.84. Its stock traded at US$68.57 at 11.20 am ET on July 26, down 0.67 percent. Its market cap is US$86 billion. The stock soared by around 18 percent YTD.

The P/E ratio and the forward P/E ratio are 299.39 and 9.68, respectively. Earnings per share are US$0.23. The current yield is 4.14 percent, and the beta is 1. The 52 weeks highest stock price of GILD is US$78.94, and the lowest is US$56.56. The share volume is 3,912,536.

GILD reported total revenues of US$6.4 billion in Q1, 2021, and US$5.5 billion in Q1, 2020. The gross profit for the quarter was US$5 billion, and that of Q1, 2020, was US$4.5 billion. Operating income for Q1, 2021, was US$2.8 billion, and that of Q1, 2020, was US$2.4 billion.

Walgreens Boots Alliance, Inc (Nasdaq: WBA)

Walgreens Boots Alliance, Inc. is a pharmacy chain, with a presence in 25 countries. The company paid a US$0.45 per share dividend in Q3, 2021. And it increased its annual dividend from US$1.87 per share to US$1.91 per share.

Its stock traded at US$47.075 at 11.14 am ET on July 26, up 1.17 percent. The market capitalization of WBA is US$39 billion. Its stock price soared by 15.77 percent YTD.

The P/E ratio and the forward P/E ratio are 17.5 and 9.60, respectively. Earnings per share are US$2.64. The current yield is 4.06 percent, and the beta is 1. The 52 week highest stock price of WBA is US$57.05, and the lowest is US$33.36. The share volume is 3,605,202.

Also read: Vaccine makers’ roundup: Pfizer, Moderna, J&J, AstraZeneca, & Sputnik

WBA reported total revenue of US$34 billion in Q1, 2021, and US$34 billion in Q1, 2020. Gross profit was US$7.1 billion in this quarter and US$5.9 billion YoY. The company reported an operating income of US$715 million, and that was in losses of US$1.6 billion YoY. Earnings per share for the quarter was US$1.38.

Please note: The above constitutes a preliminary view and any interest in stocks/cryptocurrencies should be evaluated further from an investment point of view.

Comment


Disclaimer